Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RTD (Recherche Techniques Dentaires) is a pioneering French medical device company specializing in the development and manufacture of fiber-reinforced composite posts and restorative materials for endodontics. Founded in 1968, the company is recognized as a global leader in the innovation of translucent and tooth-colored posts, which are used to provide structural support for teeth following root canal therapy. RTD's product portfolio includes well-known brands such as Macro-Lock and DT Light-Post, as well as specialized adhesives and cements designed for post-core procedures. In 2017, the company was acquired by Dentsply Sirona, the world's largest manufacturer of professional dental products, to strengthen its end-to-end 'Root to Crown' clinical solutions. Today, RTD continues to operate as a key brand within the Dentsply Sirona portfolio, serving dental professionals worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RTD.